Lars Møller Pedersen

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Postpartum Hemorrhage 56%
3. GS-5734 47%
4. Survival 44%
5. Fibrinogen 42%
6. Randomized Controlled Trials 29%
7. Ropivacaine 29%
8. Transient Receptor Potential Channels 28%
9. Coronavirus 27%
10. Follicular Lymphoma 27%
11. Urinary Retention 26%
12. Population 26%
13. Lymphoma 25%
14. Cesarean Section 25%
15. Local Anesthesia 23%
16. Fluorodeoxyglucose F18 23%
17. Therapeutics 23%
18. Hematologic Neoplasms 22%
19. Knee Replacement Arthroplasties 22%
20. Standard of Care 21%
21. Acute Kidney Injury 21%
22. Non-Hodgkin's Lymphoma 20%
23. Positron-Emission Tomography 20%
24. Critical Illness 20%
25. B-Lymphocytes 20%
26. Dexamethasone 20%
27. Rituximab 20%
28. Vascular Endothelial Growth Factor A 19%
29. Albumins 19%
30. T-Lymphocytes 17%
31. Registries 17%
32. Emergencies 17%
33. Interleukin-6 17%
34. Cohort Studies 17%
35. Pharmacokinetics 16%
36. Vaccines 16%
37. Head 16%
38. Neoplasms 14%
39. Peptides 14%
40. L-Lactate Dehydrogenase 13%
41. Hemorrhage 12%
42. Artificial Respiration 12%
43. Blood Transfusion 12%
44. Confidence Intervals 12%
45. Multivariate Analysis 11%
46. hemoglobin B 10%
47. Denmark 10%
48. Serum 10%
49. Epitopes 9%
50. Parturition 9%